ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2176

A Novel Composite Score Reflecting Disease Activity Predicts Future Knee Replacements: Data from the Osteoarthritis Initiative

Jeffrey Driban1, Matthew Harkey 2, Lori Lyn Price 3, Grace Lo 4, Jincheng Pang 5, Ming Zhang 6 and Timothy McAlindon 1, 1Tufts Medical Center, Boston, MA, 2Tufts Medical Center, University of Massachusetts Medical School, Boston, MA, 3Tufts Medical Center, Tufts University, Boston, MA, 4Center of Excellence Michael E. DeBakey VAMC, Baylor College of Medicine, Houston, TX, 5Pfizer, Inc., Cambridge, MA, 6Tufts Medical Center, Wentworth Institute of Technology, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Knee, magnetic resonance imaging (MRI) and Joint replacement, Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: While knee osteoarthritis (KOA) leads to cumulative damage to a diarthrodial joint there are also more dynamic processes that fluctuate throughout the disease process (e.g., bone marrow lesions [BMLs], effusion-synovitis). To monitor the different constructs of structural progression, we recently validated 2 magnetic resonance (MR)-based composite scores. First, the cumulative cartilage damage score represents hyaline cartilage damage throughout the knee, relates to radiographic severity, and reflects the damage attributable to KOA over the course of the disease. Secondly, the disease activity score is a composite of BMLs and effusion-synovitis volumes that relates to knee pain and reflects a patient’s current state of disease and symptoms. It is unknown if these composite scores predict poor clinical outcomes (e.g., knee replacement). Hence, we assessed adults without radiographic KOA to determine if baseline and 1-year change in cumulative cartilage damage or disease activity predicted knee replacement over the subsequent 9 years.

Methods: We performed a secondary analysis using existing MR-based data from a sex-matched nested case-control study of 3 groups from the Osteoarthritis Initiative without radiographic KOA at baseline (Kellgren-Lawrence (KL)< 2): 1) accelerated KOA: developed KL 3 or 4 within 48 months; 2) typical KOA: increase in KL grade within 48 months; 3) no KOA: no change in KL grade within 48 months.  We quantified tibiofemoral cartilage damage, BML volume, and effusion-synovitis volume with semi-automated programs. All MR-based measures were normalized to bone width and standardized, so all measurements were on the same scale. The cumulative cartilage damage score was the sum of standardized cartilage damage for the medial and lateral tibia and femur. The disease activity score was the sum of the standardized volumes of effusion-synovitis (single volumetric measure) and BML (4 locations: medial and lateral tibia and femur). The outcome was knee replacement (partial or total) that was reported or observed between the 1- and 9-year follow-up ( >96% adjudicated). For the primary analyses we combined the 3 groups and used logistic regression models to assess if baseline or 1-year change in cumulative cartilage damage or disease activity predicted knee replacement. We performed a sensitivity analysis limited to those who developed accelerated KOA.

Results: The groups were mostly female (63%) and overweight, 33% reported frequent knee pain within a year of baseline, 23% developed radiographic KOA during the first year (KL >1), and 19 people received a knee replacement between the 1- and 9-year follow-up. Greater baseline and 1-year change in disease activity, but not cumulative cartilage damage, was statistically associated with greater chance of receiving a knee replacement (Table). These findings were consistent among adults who developed accelerated KOA.

Conclusion: Prior to the onset of radiographic KOA, disease activity was associated with a knee replacement over the subsequent 9 years. This supports the construct validity of disease activity, which relates to knees symptoms that are the main reason a person would receive a knee replacement.

Table.Disease Activity is Associated with Knee Replacement Over the Subsequent 9 Years in Univariate Analyses


Disclosure: J. Driban, Pfizer, Inc., 8; M. Harkey, None; L. Price, None; G. Lo, None; J. Pang, Pfizer, Inc., 3; M. Zhang, None; T. McAlindon, None.

To cite this abstract in AMA style:

Driban J, Harkey M, Price L, Lo G, Pang J, Zhang M, McAlindon T. A Novel Composite Score Reflecting Disease Activity Predicts Future Knee Replacements: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-novel-composite-score-reflecting-disease-activity-predicts-future-knee-replacements-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-composite-score-reflecting-disease-activity-predicts-future-knee-replacements-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology